La cadena de opciones muestra datos clave de las opciones de acciones de Altice USA a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Altice USA..

Altice USA (NYSE:ATUS) Bolsa, Cadena de Opciones

Altice USA

Altice Europe acquired privately held us cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4 million U.S. homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York and i24News, a news operation focused on the Middle East.

Altice USA Inc

ALTIUS MINERALS CORP by Altius Minerals Corp.

Altius Minerals Corp

ALTICE USA CL A ORD

News

Guidance

SMCI

Supermicro Sees Q2 FY2025 Net Sales $5.5B-$6.1B, GAAP EPS $0.48-$0.58, Non-GAAP EPS $0.56-$0.65

Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 16.67 percent. This is unchanged from the same period last year. The company reported quarterly sales of $150.50 million which missed the analyst consensus estimate of $152.30 million by 1.18 percent. This is a 6.40 percent decrease over sales of $160.78 million the same period last year.

Earnings

Earnings Misses

SWIM

Latham Group Q3 EPS $0.05 Misses $0.06 Estimate, Sales $150.50M Miss $152.30M Estimate

QLYS

Qualys Raises 2024 Adj EPS Guidance From $5.46- $5.62 To $5.81 - $5.91 (Est $5.57), Lifts Revenue Guidance From $597.5M - $601.5M To $602.9M - $605.9M (Est $599.362M)

InnovAge Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INNV#NASDAQ">INNV</a>) affirms FY2025 sales outlook from $815.00 million-865.00 million to $815.00 million-865.00 million.

INNV

InnovAge Holding Affirms FY2025 Sales Guidance to $815.00M-865.00M  VS Est. 844.27M

MCHP

Microchip Sees Q3 2024 Net Sales $1.025B-$1.095B

Super Micro Computer Expects To Report Prelim. Q1 Net Sales $5.9B-$6B (Prior $6B-$7B) , Non-GAAP EPS $0.75-$0.76 (Prior $0.67-$0.83)

trivago (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVG#NASDAQ">TRVG</a>) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.02 by 300 percent. The company reported quarterly sales of $160.565 million which beat the analyst consensus estimate of $154.280 million by 4.07 percent. This is a 6.55 percent decrease over sales of $171.825 million the same period last year.

Earnings Beats

TRVG

trivago Q3 2024 GAAP EPS $(0.04) Misses $0.02 Estimate, Sales $160.565M Beat $154.280M Estimate

2024 Outlook
The company now expects:
<ul>
<li>Adjusted EBITDA, excluding reportable catastrophes6, to increase low double-digits, led by strong growth in Global Housing, with modest growth in Global Lifestyle.</li>
<li>Adjusted earnings, excluding reportable catastrophes, per diluted share6, to increase mid- to high-teens. Note: The metrics included within the company's outlook are non-GAAP financial measures and the company believes that it cannot, without unreasonable efforts, forecast certain information needed to reconcile to the GAAP measures, the probable significance of which cannot be determined. More information can be found in the Non-GAAP Financial Measures section.</li>
</ul>

Assurant Sees FY24 Adjusted EBITDA, Excluding Reportable Catastrophes, To Increase Low Double-Digits, Led By Strong Growth In Global Housing, With Modest Growth In Global Lifestyle; Adjusted Earnings, Excluding Reportable Catastrophes, Per Diluted Share, To Increase Mid- To High-Teens

InnovAge Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INNV#NASDAQ">INNV</a>) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $205.14 million which beat the analyst consensus estimate of $203.33 million by 0.89 percent. This is a 12.42 percent increase over sales of $182.49 million the same period last year.

InnovAge Holding Q1 EPS $(0.04), Inline, Sales $205.14M Beat $203.33M Estimate

Assurant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIZ#NYSE">AIZ</a>) reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.52 by 19.05 percent. This is a 30.07 percent decrease over earnings of $4.29 per share from the same period last year. The company reported quarterly sales of $2.97 billion which beat the analyst consensus estimate of $2.94 billion by 0.94 percent. This is a 6.98 percent increase over sales of $2.77 billion the same period last year.

Assurant Q3 Adj $3.00 Beats $2.52 Estimate, Sales $2.97B Beat $2.94B Estimate

Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.43 by 6.98 percent. The company reported quarterly sales of $1.164 billion which beat the analyst consensus estimate of $1.152 billion by 1.01 percent. This is a 48.36 percent decrease over sales of $2.254 billion the same period last year.

Microchip Technology Q2 2025 Adj. EPS $0.46 Beats $0.43 Estimate, Sales $1.164B Beat $1.152B Estimate

Infinera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFN#NASDAQ">INFN</a>) reported quarterly sales of $354.40 million which missed the analyst consensus estimate of $402.87 million by 12.03 percent. This is a 9.68 percent decrease over sales of $392.37 million the same period last year.

INFN

Infinera Q3 Sales $354.40M Miss $402.87M Estimate

CTKB

Cytek Biosciences Sees FY24 Revenue $203M-$210M Vs $203.937M; Sees 5-9% Revenue Growth

US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.68 by 1.47 percent. This is a 11.29 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $168.033 million which beat the analyst consensus estimate of $164.381 million by 2.22 percent. This is a 12.02 percent increase over sales of $150.007 million the same period last year.

USPH

US Physical Therapy Q3 2024 Adj. EPS $0.69 Beats $0.68 Estimate, Sales $168.033M Beat $164.381M Estimate

LUMN

Lumen Technologies Continues To Expect FY24 Adjusted EBITDA Of $3.9B - $4.0B, Net Cash Interest Of $1.15B - $1.25B

Gulfport Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPOR#NYSE">GPOR</a>) reported quarterly earnings of $3.42 per share which beat the analyst consensus estimate of $2.93 by 16.72 percent. The company reported quarterly sales of $253.912 million which missed the analyst consensus estimate of $278.980 million by 8.99 percent. This is a 11.73 percent increase over sales of $227.250 million the same period last year.

GPOR

Gulfport Energy Q3 2024 Adj. EPS $3.42 Beats $2.93 Estimate, Sales $253.912M Miss $278.980M Estimate

Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) lowers FY2024 sales outlook from $60.00 million-90.00 million to $15.00 million.

EOSE

Eos Energy Enterprises Lowers FY2024 Sales Guidance from $60.00M-90.00M to $15.00M  VS Est. 62.33M

Macrogenics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.21 by 328.57 percent. This is a 221.43 percent increase over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $110.71 million which beat the analyst consensus estimate of $76.11 million by 45.46 percent. This is a 964.81 percent increase over sales of $10.40 million the same period last year.

MGNX

Macrogenics Q3 EPS $0.90 Beats $0.21 Estimate, Sales $110.71M Beat $76.11M Estimate

Forrester Res (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORR#NASDAQ">FORR</a>) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.34 by 14.71 percent. This is a 34.09 percent decrease over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $102.527 million which beat the analyst consensus estimate of $101.944 million by 0.57 percent. This is a 9.61 percent decrease over sales of $113.431 million the same period last year.

FORR

Forrester Res Q3 2024 Adj. EPS $0.29 Misses $0.34 Estimate, Sales $102.527M Beat $101.944M Estimate

B&G Foods Sees FY24 Net Sales $1.920B-$1.950B Vs $1.951B Est.; Adj. Diluted EPS $0.67-$0.77

Notable companies reporting after the market close, with earnings consensus, include Vertex Pharmaceuticals (VRTX), consensus $4.14… Palantir (PLTR...

Notable companies reporting after market close

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER AFTER EARNINGS – QuinStreet&nbsp;(QNST)&nbsp;u...

Closing Bell Movers: Palantir jumps 13% after results

Altice USA, Inc. 2024 Q3 - Results - Earnings Call Presentation

Altice USA, Inc. (ATUS) Q3 2024 Earnings Call Transcript

Analyst Gregory Williams of TD Cowen maintained a Buy rating on Altice Usa (ATUS – Research Report), with a price target of $3.50. Gregory Williams...

Altice USA: Strategic Growth Initiatives and Financial Performance Justify Buy Rating

Altice Usa ( ($ATUS) ) has released its Q3 earnings. Here is a breakdown of the information Altice Usa presented to its investors. Altice USA is on...

Altice USA Reports Strong Fiber and Mobile Growth

Barclays analyst Kannan Venkateshwar maintained a Hold rating on Altice Usa (ATUS – Research Report) today and set a price target of $2.00. The com...

Altice Usa (ATUS) Receives a Hold from Barclays

Benchmark Co. analyst Matthew Harrigan maintained a Buy rating on Altice Usa (ATUS – Research Report) today and set a price target of $5.00. The co...

Benchmark Co. Sticks to Its Buy Rating for Altice Usa (ATUS)

TD Cowen lowered the firm's price target on Altice USA (ATUS) to $3.50 from $6 and keeps a Buy rating on the shares. The firm said they posted mixe...

Altice USA price target lowered to $3.50 from $6 at TD Cowen

In a report released today, Kutgun Maral from Evercore ISI maintained a Hold rating on Altice Usa (ATUS – Research Report), with a price target of ...

Evercore ISI Remains a Hold on Altice Usa (ATUS)

ALAB

ATUS

BOOM

BOWL

CRUS

DLTR

EVER

FANG

FWRD

GKOS

HDSN

HIMS

HOLX

ILMN

LSCC

NXPI

PLTR

QNST

SLAB

VMEO

VRTX

WYNN

Press Releases

Altice USA Reports Second Quarter 2024 Results

Lightpath Appoints Rachel Stack as Chief Financial Officer

Altice USA to Participate in the 2024 Goldman Sachs Communacopia + Technology Conference

Altice USA to Present at the 2024 Bank of America Securities Media, Communications and Entertainment Conference

Rachel Stack, CFO of Lightpath, to Speak at TMT M&A Forum USA 2024 on Fiber Industry Consolidation

Lightpath Deploys Industry's First 400G Protected Circuit Utilizing Power-Efficient Ciena WaveLogic 5 Nano Coherent Optics

Altice USA to Hold Conference Call to Discuss Q3 2024 Results

LIGHTPATH MIAMI EXPANSION INCLUDES NEW ON-NET DATA CENTERS AND RAPIDPATH DARK FIBER SERVICE

Optimum Announces Extra TV and Everything TV, Two New Video Packages That Provide More Choice, Value and Flexibility, Ushering in a New Era for Optimum TV

Comments

Altice USA

Altice USA (ATUS) Opciones

Altice USA (NYSE:ATUS) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL